Genizon BioSciences

Genizon BioSciences was a Montreal-based biotechnology company focused on discovering the genetic origins of complex diseases using the Quebec Founder Population. The company's proprietary platform utilized genome-wide association studies (GWAS) to create comprehensive 'GeneMaps' that identified novel therapeutic targets and biomarkers. Genizon successfully established high-profile collaborations with industry leaders such as Pfizer and Merck Serono to advance drug discovery in areas like Crohn's disease and respiratory disorders. Despite its innovative approach to pharmacogenomics, the company faced financial challenges and entered bankruptcy proceedings in 2011, leading to the liquidation of its intellectual property assets.